関連する実験動画
Updated: May 21, 2026
14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
p53のダイナミクスは,細胞の運命を制御する
Jeremy E Purvis1, Kyle W Karhohs, Caroline Mock
1Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.
Science (New York, N.Y.)
|June 16, 2012
まとめ
定時薬剤添加を使用して腫瘍抑制タンパク質p53の脈動行動を変化させることで,細胞の運命を変化させることができます. この研究では,p53タンパク質のダイナミクスがDNA損傷の回復と衰老にどのように影響するか示しています.
科学分野:
- 細胞のダイナミクス
- 分子シグナル伝達です.
- がん生物学 がん生物学
背景:
- 細胞は,ダイナミックなパターンを持つ複雑な分子信号を使用して通信します.
- 腫瘍抑制タンパク質p53は,DNA損傷に対するパルス反応を含む多様なダイナミックな行動を示す.
研究 の 目的:
- 細胞の運命決定に,p53タンパク質のダイナミクスを変化させることが影響するかどうかを調査する.
- 特定の薬物治療戦略を特定して,p53のシグナル伝達パターンを修正する.
主な方法:
- 細胞の反応をシミュレートするために計算モデルを使用した.
- p53の動態を調節するために,薬剤添加の正確な配列を設計し,テストしました.
- 下流の遺伝子発現と細胞運命を分析した結果 (回復 vs 老化).
主要な成果:
- 特定のタイミングによる薬物添加のシーケンスにより,p53がパルス信号から持続信号へとシフトすることが成功しました.
- 持続的なp53シグナリングは,パルスシグナリングと比較して下流遺伝子の発現を変化させた.
- パルス式p53シグナリングはDNA損傷の回復を促進し,持続的なシグナリングは頻繁な衰老につながった.
結論:
- p53のようなタンパク質のダイナミックな振る舞いは,細胞信号伝達の重要な構成要素です.
- タンパク質のダイナミクスを制御することで,細胞の運命を左右する新しい戦略が生まれ,がん治療にも影響を及ぼします.
関連する概念動画
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
02:36DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
02:36DNA Damage Can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
01:27Molecular Factors Affecting Cell Division
Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...